Chrisanthi A Karanikas

Suggest Changes
Learn More
This substudy of the AWARD-3 trial evaluated the effects of the once-weekly glucagon-like peptide-1 receptor agonist, dulaglutide, versus metformin on glucose control, pancreatic function and insulin(More)
  • 1